Colgate-Palmolive Company

CL · NYSE · USD

Financials

Annual

StatisticsIncome statementBalance sheetCash flowDividendsSegments

Valuation and market statistics · USD millions unless noted · ratios on the twelve months ending at each period

Line item	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008	FY2007	FY2006	FY2005	FY2004	FY2003	FY2002	FY2001	FY2000	FY1999	FY1998	FY1997	FY1996	FY1995	FY1994	FY1993	FY1992	FY1991	FY1990	FY1989	FY1988	FY1987	FY1986	FY1985
Valuation
Market cap	$63,695	$74,274	$65,631	$65,807	$71,929	$72,072	$58,022	$50,166	$63,593	$55,156	$56,151	$63,316	$60,697	$49,771	$45,119	$39,209	$41,029	$34,702	$39,781	$33,628	$28,579	$27,171	$26,871	$28,491	$32,165	$37,206	$37,936	$27,456	$21,673	$13,476	$10,158	$9,265	$9,724	$8,713	$6,695	$4,875	$4,289	$3,141	$2,622	$2,821	$1,906
Enterprise value	$71,165	$81,862	$73,898	$74,708	$79,292	$79,756	$66,063	$56,105	$68,938	$60,634	$61,984	$68,615	$65,623	$54,318	$49,217	$42,285	$43,752	$38,051	$42,977	$36,809	$31,685	$30,788	$29,708	$31,927	$35,232	$39,972	$40,490	$30,032	$24,167	$16,297	$13,182	$11,055	$11,297	$9,733	$7,584	$6,051	$5,062	$3,555	$3,476	$3,333	$2,543
P/E (TTM) at period end	29.88×	25.71×	28.54×	36.87×	33.21×	26.74×	24.51×	20.90×	31.42×	22.60×	40.57×	29.04×	27.08×	20.13×	18.56×	18.08×	18.15×	17.99×	22.90×	24.85×	21.15×	20.47×	18.91×	22.12×	28.05×	34.97×	40.47×	32.35×	29.27×	21.22×	59.06×	15.97×	51.21×	18.27×	53.61×	15.19×	15.32×	16.29×	48.55×	15.89×	11.09×
P/S (TTM) at period end	3.13×	3.70×	3.37×	3.66×	4.13×	4.38×	3.70×	3.23×	4.11×	3.63×	3.50×	3.66×	3.48×	2.91×	2.70×	2.52×	2.68×	2.26×	2.88×	2.75×	2.51×	2.57×	2.71×	3.07×	3.41×	3.98×	4.16×	3.06×	2.39×	1.54×	1.22×	1.22×	1.36×	1.24×	1.10×	0.86×	0.85×	0.66×	0.46×	0.57×	0.42×
P/B at period end	1179.54×	350.35×	107.77×	164.11×	118.11×	97.00×	495.91×	–	–	–	–	55.30×	26.33×	22.74×	19.00×	14.66×	13.17×	18.05×	17.40×	23.83×	21.17×	21.82×	30.29×	81.33×	38.00×	25.34×	20.69×	13.16×	9.95×	6.62×	6.05×	5.08×	5.19×	3.33×	3.59×	3.58×	3.82×	2.76×	2.82×	2.92×	2.13×
EV / EBITDA (TTM)	18.08×	16.80×	16.24×	21.73×	20.39×	18.03×	16.22×	13.34×	16.48×	13.79×	19.14×	17.16×	16.43×	12.59×	11.55×	10.94×	11.03×	11.03×	14.07×	12.69×	11.74×	12.17×	11.97×	13.82×	16.03×	19.42×	20.45×	16.55×	14.40×	10.43×	9.25×	8.61×	9.71×	9.82×	17.73×	8.89×	9.51×	–	–	–	–
EV / Sales (TTM)	3.49×	4.07×	3.80×	4.16×	4.55×	4.84×	4.21×	3.61×	4.46×	3.99×	3.87×	3.97×	3.77×	3.18×	2.94×	2.72×	2.85×	2.48×	3.12×	3.01×	2.78×	2.91×	3.00×	3.44×	3.74×	4.27×	4.44×	3.35×	2.67×	1.86×	1.58×	1.46×	1.58×	1.39×	1.25×	1.06×	1.00×	0.75×	0.62×	0.67×	0.56×
Returns
Return on equity	3948.1%	1362.7%	377.7%	445.1%	355.7%	362.7%	2023.1%	–	–	–	–	190.4%	97.2%	112.9%	102.4%	81.1%	72.6%	100.3%	76.0%	95.9%	100.1%	106.6%	160.2%	367.8%	135.5%	72.5%	51.1%	40.7%	34.0%	31.2%	10.2%	31.8%	10.1%	18.2%	6.7%	23.5%	24.9%	16.9%	5.8%	18.3%	19.2%
Return on invested capital	32.0%	41.3%	31.8%	23.0%	31.7%	36.2%	33.3%	46.7%	43.7%	52.3%	28.2%	36.5%	33.2%	39.2%	40.0%	40.9%	41.9%	39.9%	34.9%	38.4%	35.1%	30.4%	40.5%	36.6%	32.7%	27.5%	24.9%	21.6%	19.5%	17.1%	11.3%	19.2%	18.1%	14.4%	5.9%	13.7%	14.4%	14.3%	9.5%	13.4%	11.0%
Dividend yield	2.9%	2.4%	2.7%	2.6%	2.3%	2.3%	2.8%	3.2%	2.4%	2.7%	2.7%	2.3%	2.3%	2.6%	2.7%	2.9%	2.4%	2.6%	1.9%	2.0%	2.1%	2.0%	1.9%	1.5%	1.2%	1.0%	1.0%	1.3%	1.5%	2.2%	2.7%	2.7%	2.4%	2.3%	2.3%	2.8%	2.7%	–	–	–	–
Financial health
Current ratio	0.83×	0.92×	1.11×	1.28×	1.09×	0.99×	1.03×	1.14×	1.36×	1.31×	1.24×	1.23×	1.08×	1.22×	1.18×	1.00×	1.06×	1.26×	1.14×	0.95×	1.01×	1.00×	1.02×	1.04×	1.04×	1.05×	1.04×	1.06×	1.12×	1.25×	1.35×	1.42×	1.49×	1.47×	1.47×	1.40×	1.92×	1.66×	1.34×	1.41×	1.46×
Debt / equity	147.89×	37.46×	13.53×	21.83×	11.83×	9.88×	64.85×	(62.29×)	(109.43×)	(26.83×)	(21.89×)	5.36×	2.45×	2.36×	2.01×	1.26×	1.01×	1.91×	1.54×	2.60×	2.55×	2.95×	3.50×	10.29×	3.83×	2.03×	1.52×	1.32×	1.23×	1.51×	1.92×	1.07×	0.92×	0.43×	0.57×	0.98×	1.04×	0.69×	0.98×	0.70×	1.00×
Effective tax rate	26.1%	22.9%	27.6%	26.1%	24.3%	21.6%	23.4%	26.2%	37.7%	30.8%	44.0%	33.8%	32.4%	32.1%	32.6%	32.6%	32.2%	32.2%	29.6%	31.5%	34.1%	32.9%	30.4%	31.1%	31.3%	32.1%	32.8%	32.1%	32.8%	33.5%	52.7%	34.1%	34.5%	34.5%	42.7%	37.2%	37.3%	39.0%	56.0%	40.2%	39.1%
Share count
Diluted shares outstanding	811	823	829	839	848	859	861	873	888	898	910	924	940	960	984	1,022	1,049	1,070	1,068	1,077	1,089	1,117	1,135	1,157	1,190	1,227	1,247	1,273	1,273	1,252	1,157	1,255	1,295	1,323	1,096	1,137	1,122	1,068	1,070	1,106	930

StatisticsIncome statementBalance sheetCash flowDividendsSegments

Income statement · USD millions

Line item	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008	FY2007	FY2006	FY2005	FY2004	FY2003	FY2002	FY2001	FY2000	FY1999	FY1998	FY1997	FY1996	FY1995	FY1994	FY1993	FY1992	FY1991	FY1990	FY1989	FY1988	FY1987	FY1986	FY1985
Revenue and gross profit
Revenue	$21,046	$20,382	$20,101	$19,457	$17,967	$17,421	$16,471	$15,693	$15,544	$15,454	$15,195	$16,034	$17,277	$17,420	$17,085	$16,734	$15,564	$15,327	$15,330	$13,790	$12,238	$11,397	$10,584	$9,903	$9,294	$9,428	$9,358	$9,118	$8,972	$9,057	$8,749	$8,358	$7,588	$7,141	$7,007	$6,060	$5,691	$5,039	$4,734	$5,648	$4,985	$4,524
Cost of revenue	($8,329)	($8,131)	($7,940)	($8,131)	($7,719)	($7,046)	($6,454)	($6,368)	($6,313)	($6,174)	($6,072)	($6,635)	($7,168)	($7,219)	($7,153)	($7,144)	($6,360)	($6,319)	($6,704)	($6,043)	($5,356)	($5,107)	($4,758)	($4,456)	($4,224)	($4,237)	($4,266)	($3,884)	($3,960)	($4,142)	($4,135)	($4,053)	($3,678)	($3,520)	($3,516)	($3,150)	($2,995)	($2,746)	($2,643)	($3,068)	($2,803)	($2,608)
Gross profit	$12,717	$12,251	$12,161	$11,326	$10,248	$10,375	$10,017	$9,325	$9,231	$9,280	$9,123	$9,399	$10,109	$10,201	$9,932	$9,590	$9,204	$9,008	$8,626	$7,747	$6,882	$6,290	$5,826	$5,447	$5,070	$5,191	$5,092	$5,234	$5,012	$4,915	$4,614	$4,305	$3,910	$3,621	$3,491	$2,910	$2,696	$2,293	$2,091	$2,580	$2,182	$1,915
Operating expenses
Research and development	–	($366)	($355)	($343)	($320)	($307)	($290)	($281)	($277)	($285)	($289)	($274)	($277)	($267)	($259)	($262)	($256)	($256)	($240)	($247)	($242)	($246)	($229)	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, general and administrative	($8,247)	($7,903)	($7,729)	($7,151)	($6,565)	($6,407)	($6,019)	($5,575)	($5,389)	($5,400)	($5,143)	($5,464)	($5,982)	($6,223)	($5,930)	($5,758)	($5,414)	($5,282)	($5,422)	($4,973)	($4,068)	($3,673)	($3,395)	($3,296)	($3,034)	($3,262)	($3,300)	($3,254)	($3,197)	($3,237)	($3,052)	($2,880)	($2,625)	($2,457)	($2,500)	($2,482)	($2,016)	($1,760)	($1,646)	($2,094)	($1,760)	($1,566)
Total operating expenses	($9,586)	($8,945)	($7,893)	($7,342)	($7,355)	($7,043)	($6,132)	($5,771)	($5,537)	($5,573)	($5,168)	($6,610)	($6,552)	($6,645)	($6,043)	($5,749)	($5,715)	($5,393)	($5,525)	($5,027)	($4,309)	($3,919)	($3,625)	($3,281)	($3,057)	($3,330)	($3,372)	($3,595)	($3,527)	($3,557)	($3,368)	($3,180)	($2,860)	($2,667)	($2,693)	($2,629)	($2,142)	($1,857)	($1,728)	($2,196)	($1,849)	($1,638)
Total costs and expenses	($17,915)	($17,076)	($15,833)	($15,473)	($15,074)	($14,089)	($12,586)	($12,139)	($11,850)	($11,747)	($11,240)	($13,245)	($13,720)	($13,864)	($13,196)	($12,893)	($12,075)	($11,712)	($12,229)	($11,070)	($9,665)	($9,026)	($8,383)	($7,737)	($7,281)	($7,566)	($7,637)	($7,478)	($7,487)	($7,698)	($7,503)	($7,233)	($6,538)	($6,187)	($6,209)	($5,779)	($5,137)	($4,603)	($4,371)	($5,264)	($4,652)	($4,247)
Operating income	$3,131	$3,306	$4,268	$3,984	$2,893	$3,332	$3,885	$3,554	$3,694	$3,707	$3,955	$2,789	$3,557	$3,556	$3,889	$3,841	$3,489	$3,615	$3,101	$2,720	$2,572	$2,371	$2,202	$2,166	$2,013	$1,861	$1,721	$1,640	$1,484	$1,358	$1,246	$1,126	$1,049	$954	$799	$282	$555	$435	$364	$384	$332	$277
Earnings
EBITDA	$3,773	$3,936	$4,873	$4,551	$3,438	$3,888	$4,424	$4,073	$4,205	$4,182	$4,398	$3,238	$3,999	$3,995	$4,314	$4,262	$3,865	$3,966	$3,449	$3,054	$2,901	$2,700	$2,529	$2,482	$2,310	$2,198	$2,058	$1,980	$1,814	$1,678	$1,562	$1,426	$1,284	$1,164	$991	$428	$681	$532	–	–	–	–
Interest income	$73	$75	$67	$55	$14	$17	$19	$47	$50	$51	$50	$107	$106	$125	$65	$6	$6	$11	$10	$10	$8	$6	$4	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Interest expense	($255)	($267)	($292)	($287)	($167)	($120)	($184)	($193)	($195)	($156)	($155)	($139)	($134)	($119)	($81)	($59)	($69)	($102)	($115)	($167)	($167)	($142)	($124)	–	–	($2,021)	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Pre-tax income	$2,942	$3,059	$3,956	$3,392	$2,660	$3,087	$3,647	$3,301	$3,464	$3,487	$3,738	$2,763	$3,533	$3,565	$3,874	$3,789	$3,430	$3,538	$3,005	$2,564	$2,059	$2,134	$2,050	$2,042	$1,870	$1,669	$1,567	$1,395	$1,250	$1,102	$955	$364	$880	$836	$728	$218	$511	$447	$250	$123	$297	$276
Income tax expense	($781)	($798)	($907)	($937)	($693)	($749)	($787)	($774)	($906)	($1,313)	($1,152)	($1,215)	($1,194)	($1,155)	($1,243)	($1,235)	($1,117)	($1,141)	($968)	($759)	($648)	($728)	($675)	($621)	($582)	($522)	($503)	($457)	($402)	($362)	($320)	($192)	($300)	($288)	($251)	($93)	($190)	($167)	($98)	($69)	($120)	($108)
Net income	$2,037	$2,132	$2,889	$2,300	$1,785	$2,166	$2,695	$2,367	$2,400	$2,024	$2,441	$1,384	$2,180	$2,241	$2,472	$2,431	$2,203	$2,291	$1,957	$1,737	$1,353	$1,351	$1,327	$1,421	$1,288	$1,147	$1,064	$937	$849	$740	$635	$172	$580	$190	$477	$125	$321	$280	$193	$54	$178	$172
Per share
Diluted EPS (GAAP)	$2.52	$2.63	$3.51	$2.77	$2.13	$2.55	$3.14	$2.75	$2.75	$2.28	$2.72	$1.52	$2.36	$2.38	$2.57	$2.47	$2.15	$2.19	$1.83	$1.60	$1.23	$1.22	$1.17	$1.23	$1.10	$0.95	$0.85	$0.74	$0.65	$0.56	$0.49	$0.13	$0.45	$0.13	$0.35	$0.095	$0.27	$0.24	$0.18	$0.05	$0.16	$0.14
Basic EPS (GAAP)	$2.54	$2.64	$3.53	$2.78	$2.13	$2.56	$3.15	$2.76	$2.76	$2.30	$2.74	$1.53	$2.38	$2.41	$2.60	$2.49	$2.23	$2.27	$1.91	$1.68	$1.29	$1.27	$1.23	$1.30	$1.17	$1.01	$0.91	$0.79	$0.70	$0.61	$0.53	$0.13	$0.48	$0.14	$0.37	$0.095	$0.28	$0.25	$0.18	$0.05	$0.16	$0.14
Basic shares outstanding	804	809	819	827	836	845	857	859	871	882	892	902	915	931	952	977	976	999	1,013	1,021	1,031	1,042	1,062	1,074	1,087	1,114	1,153	1,167	1,182	1,179	1,169	1,157	1,170	1,247	1,250	1,096	1,058	1,078	1,068	1,070	1,106	930
Margins
Gross margin	60.4%	60.1%	60.5%	58.2%	57.0%	59.6%	60.8%	59.4%	59.4%	60.0%	60.0%	58.6%	58.5%	58.6%	58.1%	57.3%	59.1%	58.8%	56.3%	56.2%	56.2%	55.2%	55.0%	55.0%	54.6%	55.1%	54.4%	57.4%	55.9%	54.3%	52.7%	51.5%	51.5%	50.7%	49.8%	48.0%	47.4%	45.5%	44.2%	45.7%	43.8%	42.3%
Operating margin	14.9%	16.2%	21.2%	20.5%	16.1%	19.1%	23.6%	22.6%	23.8%	24.0%	26.0%	17.4%	20.6%	20.4%	22.8%	23.0%	22.4%	23.6%	20.2%	19.7%	21.0%	20.8%	20.8%	21.9%	21.7%	19.7%	18.4%	18.0%	16.5%	15.0%	14.2%	13.5%	13.8%	13.4%	11.4%	4.6%	9.7%	8.6%	7.7%	6.8%	6.7%	6.1%
Net margin	9.7%	10.5%	14.4%	11.8%	9.9%	12.4%	16.4%	15.1%	15.4%	13.1%	16.1%	8.6%	12.6%	12.9%	14.5%	14.5%	14.2%	14.9%	12.8%	12.6%	11.1%	11.9%	12.5%	14.4%	13.9%	12.2%	11.4%	10.3%	9.5%	8.2%	7.3%	2.1%	7.6%	2.7%	6.8%	2.1%	5.6%	5.6%	4.1%	1.0%	3.6%	3.8%

Analyst consensus

Hold45 analysts

Bearish · 2 · Hold · 25 · Bullish · 18

Earnings history

	EPS	Estimate
Q3 2024	$0.91	$0.89	Beat
Q4 2024	$0.91	$0.90	Beat
Q1 2025	$0.91	$0.86	Beat
Q2 2025	$0.92	$0.90	Beat
Q3 2025	$0.91	$0.89	Beat
Q4 2025	$0.95	$0.91	Beat
Q1 2026	$0.97	$0.94	Beat
Q2 2026	$0.99	$0.95	Beat

Peers

Company overview

IPO dateMay 2, 1973

CEONoel R. Wallace

Employees33,600

SectorConsumer Defensive

IndustryHousehold & Personal Products

CountryUS

ExchangeNew York Stock Exchange

Websitewww.colgatepalmolive.com

Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care division encompasses a broad array of offerings, spanning oral hygiene (e.g., toothpastes, toothbrushes, mouthwashes), personal care (e.g., bar and liquid soaps, shower gels, shampoos, conditioners, deodorants, antiperspirants, skin health items), and home care solutions (e.g., dishwashing detergents, fabric conditioners, household cleaners). These products are distributed through various channels, including traditional and online retailers, wholesalers, and distributors, under well-known brand names such as Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly. Furthermore, this segment supplies specialized pharmaceutical products to dentists and other professionals in oral healthcare. Conversely, the Pet Nutrition segment focuses on providing specialized pet food. This includes everyday nutritional options marketed under the Hill's Science Diet brand, as well as therapeutic diets designed to assist in managing various health conditions in dogs and cats, sold under the Hill's Prescription Diet brand. Distribution for these pet nutrition items occurs via pet supply stores, veterinary clinics, and online retail platforms. Established in 1806, Colgate-Palmolive Company maintains its corporate headquarters in New York, New York.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.